Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Fusco

Showing results (61-70 of 281) with videos related to

Pageof 29
Sort By:
The EMBO Journal|March 10, 2007
Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcriptionLaura Casalino, Latifa Bakiri, Francesco Talotta, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 2, 2006
Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase etaHuita C Matozo, Alessandro S Nascimento, Maria A M Santos, et al.
The Journal of Clinical Investigation|February 10, 2007
High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2Giovanna Maria Pierantoni, Cinzia Rinaldo, Marcella Mottolese, et al.
European Thyroid Journal|March 12, 2015
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas)Mario Monaco, Gennaro Chiappetta, Concetta Aiello, et al.
Nucleic Acids Research|December 15, 2007
siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinomaHenri de Martimprey, Jean-Remi Bertrand, Alfredo Fusco, et al.
Oncogene|June 9, 2004
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitorsFrancesca Carlomagno, Teresa Guida, Suresh Anaganti, et al.
Endocrine-Related Cancer|September 7, 2010
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionSamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
Molecular Endocrinology (Baltimore, Md.)|October 6, 2006
An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase etaSara Arena, Alessandra Pattarozzi, Alessandro Massa, et al.
Molecular Endocrinology (Baltimore, Md.)|August 6, 2011
A TSH-CREB1-microRNA loop is required for thyroid cell growthVincenza Leone, Daniela D'Angelo, Angelo Ferraro, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutationsGiuliana Salvatore, Gennaro Chiappetta, Yuri E Nikiforov, et al.
Pageof 29

Showing results (61-70 of 281) with videos related to

Sort By:
Pageof 29
The EMBO Journal|March 10, 2007
Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcriptionLaura Casalino, Latifa Bakiri, Francesco Talotta, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 2, 2006
Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase etaHuita C Matozo, Alessandro S Nascimento, Maria A M Santos, et al.
The Journal of Clinical Investigation|February 10, 2007
High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2Giovanna Maria Pierantoni, Cinzia Rinaldo, Marcella Mottolese, et al.
European Thyroid Journal|March 12, 2015
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas)Mario Monaco, Gennaro Chiappetta, Concetta Aiello, et al.
Nucleic Acids Research|December 15, 2007
siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinomaHenri de Martimprey, Jean-Remi Bertrand, Alfredo Fusco, et al.
Oncogene|June 9, 2004
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitorsFrancesca Carlomagno, Teresa Guida, Suresh Anaganti, et al.
Endocrine-Related Cancer|September 7, 2010
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionSamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
Molecular Endocrinology (Baltimore, Md.)|October 6, 2006
An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase etaSara Arena, Alessandra Pattarozzi, Alessandro Massa, et al.
Molecular Endocrinology (Baltimore, Md.)|August 6, 2011
A TSH-CREB1-microRNA loop is required for thyroid cell growthVincenza Leone, Daniela D'Angelo, Angelo Ferraro, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutationsGiuliana Salvatore, Gennaro Chiappetta, Yuri E Nikiforov, et al.
Pageof 29